Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 2006;26:442-448
Published online before print December 22, 2005, doi: 10.1161/01.ATV.0000201282.64751.47
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
26/3/442    most recent
01.ATV.0000201282.64751.47v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Heeren, J.
Right arrow Articles by Grewal, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Heeren, J.
Right arrow Articles by Grewal, T.
Right arrowPubmed/NCBI databases
*Genetics Home Reference
Related Collections
Right arrow Pathophysiology
Right arrow Cell biology/structural biology
Right arrow Lipid and lipoprotein metabolism
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2006;26:442.)
© 2006 American Heart Association, Inc.


Brief Reviews

Apolipoprotein E Recycling

Implications for Dyslipidemia and Atherosclerosis

Joerg Heeren; Ulrike Beisiegel; Thomas Grewal

From the Institute for Biochemistry and Molecular Biology II (J.H., U.B.), Molecular Cell Biology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; and Centre for Immunology (T.G.), St. Vincent’s Hospital, University of New South Wales, Darlinghurst, Sydney, Australia.

Correspondence to Dr Joerg Heeren, IBM II, Molecular Cell Biology, University Hospital Eppendorf, Martinistrasse 52, D-20246 Hamburg, Germany. E-mail heeren{at}uke.uni-hamburg.de

After receptor-mediated endocytosis, the intracellular fate of triglyceride-rich lipoproteins (TRLs) is far more complex than the classical degradation pathway of low-density lipoproteins. Once internalized, TRLs disintegrate in peripheral endosomes, followed by a differential sorting of TRL components. Although core lipids and apolipoprotein B are targeted to lysosomes, the majority of TRL-derived apolipoprotein E (apoE) remains in peripheral recycling endosomes. This pool of TRL-derived apoE is then mobilized by high-density lipoproteins (HDLs) or HDL-derived apoA-I to be recycled back to the plasma membrane, followed by apoE resecretion and the subsequent formation of apoE-containing HDL. The HDL-induced recycling of apoE is accompanied by cholesterol efflux and involves the internalization and targeting of HDL-derived apoA-I to endosomes containing both apoE and cholesterol. These findings point to a yet unknown intracellular link between TRL-derived apoE, cellular cholesterol transport, and HDL metabolism. Recent studies provide first evidence that impaired recycling of TRL-derived apoE4, but not apoE3, is associated with intracellular cholesterol accumulation, which might explain some well-documented effects of apoE4 on HDL metabolism. This review summarizes the current understanding of apoE recycling and its potential role in the regulation of plasma apoE levels in the postprandial state.


Key Words: apolipoprotein E • HDL • endocytosis • cholesterol efflux • triglyceride-rich lipoproteins




This article has been cited by other articles:


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
B. W. Parks, R. Srivastava, S. Yu, and J. H.S. Kabarowski
ApoE-Dependent Modulation of HDL and Atherosclerosis by G2A in LDL Receptor-Deficient Mice Independent of Bone Marrow-Derived Cells
Arterioscler Thromb Vasc Biol, April 1, 2009; 29(4): 539 - 547.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
G. S. Getz and C. A. Reardon
Apoprotein E as a lipid transport and signaling protein in the blood, liver, and artery wall
J. Lipid Res., April 1, 2009; 50(Supplement): S156 - S161.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. A. Ruby, D. K. Nomura, C. S. S. Hudak, L. M. Mangravite, S. Chiu, J. E. Casida, and R. M. Krauss
Overactive endocannabinoid signaling impairs apolipoprotein E-mediated clearance of triglyceride-rich lipoproteins
PNAS, September 23, 2008; 105(38): 14561 - 14566.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. K. Nilsson, S. Christensen, M. K. Raarup, R. O. Ryan, M. S. Nielsen, and G. Olivecrona
Endocytosis of Apolipoprotein A-V by Members of the Low Density Lipoprotein Receptor and the Vps10p Domain Receptor Families
J. Biol. Chem., September 19, 2008; 283(38): 25920 - 25927.
[Abstract] [Full Text] [PDF]


Home page
Physiol. GenomicsHome page
N. Tiffin, I. Okpechi, C. Perez-Iratxeta, M. A. Andrade-Navarro, and R. Ramesar
Prioritization of candidate disease genes for metabolic syndrome by computational analysis of its defining phenotypes
Physiol Genomics, September 17, 2008; 35(1): 55 - 64.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
M. Kockx, W. Jessup, and L. Kritharides
Regulation of Endogenous Apolipoprotein E Secretion by Macrophages
Arterioscler Thromb Vasc Biol, June 1, 2008; 28(6): 1060 - 1067.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. ProteomicsHome page
M. Heller, E. Schlappritzi, D. Stalder, J.-M. Nuoffer, and A. Haeberli
Compositional Protein Analysis of High Density Lipoproteins in Hypercholesterolemia by Shotgun LC-MS/MS and Probabilistic Peptide Scoring
Mol. Cell. Proteomics, June 1, 2007; 6(6): 1059 - 1072.
[Abstract] [Full Text] [PDF]